135 related articles for article (PubMed ID: 23259335)
1. [Control of hepatocellular carcinoma progression by the tumor microenvironment].
Clement B
Bull Acad Natl Med; 2012 Jan; 196(1):75-84. PubMed ID: 23259335
[TBL] [Abstract][Full Text] [Related]
2. The tumor microenvironment in hepatocellular carcinoma (review).
Leonardi GC; Candido S; Cervello M; Nicolosi D; Raiti F; Travali S; Spandidos DA; Libra M
Int J Oncol; 2012 Jun; 40(6):1733-47. PubMed ID: 22447316
[TBL] [Abstract][Full Text] [Related]
3. Role of the microenvironment in hepatocellular carcinoma development and progression.
Wu SD; Ma YS; Fang Y; Liu LL; Fu D; Shen XZ
Cancer Treat Rev; 2012 May; 38(3):218-25. PubMed ID: 21763074
[TBL] [Abstract][Full Text] [Related]
4. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenviroment and hepatocellular carcinoma metastasis.
Wang H; Chen L
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():43-8. PubMed ID: 23855295
[TBL] [Abstract][Full Text] [Related]
7. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.
Yang C; Zeisberg M; Lively JC; Nyberg P; Afdhal N; Kalluri R
Cancer Res; 2003 Dec; 63(23):8312-7. PubMed ID: 14678990
[TBL] [Abstract][Full Text] [Related]
9. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?
Wu XZ; Chen D; Xie GR
Med Hypotheses; 2006; 66(6):1115-20. PubMed ID: 16504415
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of matrix metalloproteinases.
Mannello F; Medda V
Prog Histochem Cytochem; 2012 Mar; 47(1):27-58. PubMed ID: 22226510
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.
Tahmasebi Birgani M; Carloni V
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216578
[TBL] [Abstract][Full Text] [Related]
15. Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma.
Fang M; Peng CW; Yuan JP; Zhang ZL; Pang DW; Li Y
Future Oncol; 2013 Jul; 9(7):1029-37. PubMed ID: 23837765
[TBL] [Abstract][Full Text] [Related]
16. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
Sukowati CH; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
[TBL] [Abstract][Full Text] [Related]
17. [Matrix metalloproteinase (MMP), matrix serine proteinase (MSP), tissue inhibitor of metalloproteinase (TIMP)].
Mafune K
Nihon Rinsho; 2001 Oct; 59 Suppl 6():176-83. PubMed ID: 11761937
[No Abstract] [Full Text] [Related]
18. Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.
Novikova MV; Khromova NV; Kopnin PB
Biochemistry (Mosc); 2017 Aug; 82(8):861-873. PubMed ID: 28941454
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms of hepatocellular carcinoma: an update.
Aravalli RN; Cressman EN; Steer CJ
Arch Toxicol; 2013 Feb; 87(2):227-47. PubMed ID: 23007558
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
